Skip to nav Skip to content
Nate  Parker

Nate Parker, MPH, PhD

Program: Health Outcomes and Behavior

Research Program: Health Outcomes & Behavior Program


  • Overview

    Dr. Parker conducts behavioral research in exercise oncology.


    • Health Outcomes and Behavior
    • Gastrointestinal Oncology
    • Health Outcomes & Behavior Program

    Education & Training


    • University of Texas School of Public Health, MPH - Epidemiology
    • University of Houston, PhD - Kinesiology
  • Research Interest

    Dr. Parker’s research focuses on designing and evaluating exercise interventions, particularly involving resistance training, to improve cancer treatment outcomes and cancer survivorship.

  • Participating Trials

    Clinical Trial 21742
    Remote Resistance Exercise Powering Survivors- Gastrointestinal Oncology (Remote REPS-:GI)
    Condition: Gastrointestinal Tumor
    Status: Open

    Clinical Trial 22115
    Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
    Condition: Malignant Hematology
    Status: Open

    Clinical Trial 22455
    Project Rally: Enhancing Cancer Survivorship with Pickleball
    Condition: Multiple
    Status: Open

    Clinical Trial 23088
    Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer: A Randomized Pilot Study
    Condition: Gastrointestinal Tumor
    Status: Open

    Clinical Trial 23121
    Exercise Prehabilitation for Locoregional Esophageal Cancer: A Pilot Study
    Condition: Gastrointestinal Tumor
    Status: Open

    If you believe you are eligible for one of these trials or studies, please call
    813-745-6100 or toll-free 1-800-679-0775.

  • Publications

    • Akhtar OS, Modi K, Kim J, Skellson L, Smith E, Al-Jumayli MA, Extermann M, De Avila G, Parker N, Castaneda-Puglianini O, Grajales-Cruz A, Baz R, Blue B, Shain K, Alsina M, Liu H, Nishihori T, Jain MD, Locke FL, Hansen DK, Freeman CL. Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy. Transplant Cell Ther. 2024 Mar.30(3):283.e1-283.e10. Pubmedid: 38123069.
    • Turner K, Kim DW, Gonzalez BD, Gore LR, Gurd E, Milano J, Riccardi D, Byrne M, Al-Jumayli M, de Castria TB, Laber DA, Hoffe S, Costello J, Robinson E, Chadha JS, Rajasekhara S, Hume E, Hagen R, Nguyen OT, Nardella N, Parker N, Carson TL, Tabriz AA, Hodul P. Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trial. Contemp Clin Trials Commun. 2024 Apr.38:101271. Pubmedid: 38440777. Pmcid: PMC10910065.
    • Rejeski K, Cordas Dos Santos DM, Parker NH, Bücklein VL, Winkelmann M, Jhaveri KS, Liu L, Trinkner P, Günther S, Karschnia P, Blumenberg V, Schmidt C, Kunz WG, von Bergwelt-Baildon M, Jain MD, Theurich S, Subklewe M. Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy. Cancer Immunol Res. 2023 Jun.11(6):707-719. Pubmedid: 37040425. Pmcid: PMC10236147.
    • Ngo-Huang AT, Parker NH, Xiao LC, Schadler KL, Petzel MQB, Prakash LR, Kim MP, Tzeng CD, Lee JE, Ikoma N, Wolff RA, Javle MM, Koay EJ, Pant SD, Folloder JP, Wang X, Cotto AM, Ju YR, Garg N, Wang H, Bruera ED, Basen-Engquist KM, Katz MHG. Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial. Ann Surg. 2023 Jul.278(1):22-30. Pubmedid: 37026453. Pmcid: PMC10330108.
    • Sleight AG, Crowder SL, Skarbinski J, Coen P, Parker NH, Hoogland AI, Gonzalez BD, Playdon MC, Cole S, Ose J, Murayama Y, Siegel EM, Figueiredo JC, Jim HSL. A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk Prediction and Clinical Care. Cancers (Basel). 2022 Apr.14(8). Pubmedid: 35454890. Pmcid: PMC9027717.
    • Robertson MC, Lee CY, Wu IH, Liao Y, Raber M, Parker N, Le T, Gatus L, Basen-Engquist KM. Changes in physical activity associated with the COVID-19 pandemic in individuals with overweight and obesity: an interrupted time series analysis with historical controls. J Behav Med. 2022 Apr.45(2):186-196. Pubmedid: 34698998. Pmcid: PMC8546384.
    • Soltero EG, Parker NH, Mama DrPH SK, Ledoux TA, Lee RE. Lessons Learned From Implementing of Garden Education Program in Early Child Care. Health Promot Pract. 2021 Mar.22(2):266-274. Pubmedid: 31470753. Pmcid: PMC9014813.
    • Lee RE, Parker NH, Hallett AM, Kao D, Modelska MJ, Rifai HS, Soltero EG, O'Connor DP. Stakeholder perspectives and sustainability of an integrated care model for the prevention and management of obesity: the Childhood Obesity Research Demonstration (CORD) project. Transl Behav Med. 2021 Mar.11(2):393-407. Pubmedid: 32667038.
    • Parker NH, Gorzelitz J, Ngo-Huang A, Caan BJ, Prakash L, Garg N, Petzel MQB, Schadler K, Basen-Engquist K, Katz MHG. The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment. Integr Cancer Ther. 2021 Jan.20. Pubmedid: 33870744. Pmcid: PMC8056559.
    • Carmack CL, Parker NH, Demark-Wahnefried W, Shely L, Baum G, Yuan Y, Giordano SH, Rodriguez-Bigas M, Pettaway C, Basen-Engquist K. Healthy Moves to Improve Lifestyle Behaviors of Cancer Survivors and Their Spouses: Feasibility and Preliminary Results of Intervention Efficacy. Nutrients. 2021 Dec.13(12). Pubmedid: 34960013. Pmcid: PMC8709140.
    • Parker NH, Basen-Engquist K, Rubin ML, Li Y, Prakash L, Ngo-Huang A, Gorzelitz J, Ikoma N, Lee JE, Katz MHG. Factors Influencing Exercise Following Pancreatic Tumor Resection. Ann Surg Oncol. 2021 Apr.28(4):2299-2309. Pubmedid: 32886288.
    • Parker NH, Katz MHG. ASO Author Reflections: It is Time to Prioritize Exercise in Pancreatic Cancer Survivorship. Ann Surg Oncol. 2021 Apr.28(4):2310-2311. Pubmedid: 32886285. Pmcid: PMC8300571.
    • Lee RE, Kao D, Parker NH, Hallett AM, Kochi CY, Modelska MJ, Rifai HS, O'Connor DP. Evaluating sustainability in the Childhood Obesity Research Demonstration project: the model and process. Arch Public Health. 2020 Feb.78:13. Pubmedid: 32082567. Pmcid: PMC7017491.
    • Florez Bedoya CA, Cardoso ACF, Parker N, Ngo-Huang A, Petzel MQ, Kim MP, Fogelman D, Romero SG, Wang H, Park M, Katz MHG, Schadler KL. Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients. Sci Rep. 2019 Sep.9(1):13966. Pubmedid: 31562341. Pmcid: PMC6765012.
    • Ngo-Huang A, Holmes HM, des Bordes JKA, Parker NH, Fogelman D, Petzel MQB, Song J, Bruera E, Katz MHG. Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma. Cancer Med. 2019 Jun.8(6):2867-2876. Pubmedid: 31033241. Pmcid: PMC6558581.
    • Parker NH, Ngo-Huang A, Lee RE, O'Connor DP, Basen-Engquist KM, Petzel MQB, Wang X, Xiao L, Fogelman DR, Schadler KL, Simpson RJ, Fleming JB, Lee JE, Varadhachary GR, Sahai SK, Katz MHG. Physical activity and exercise during preoperative pancreatic cancer treatment. Support Care Cancer. 2019 Jun.27(6):2275-2284. Pubmedid: 30334105. Pmcid: PMC8390123.
    • Ngo-Huang A, Parker NH, Bruera E, Lee RE, Simpson R, O'Connor DP, Petzel MQB, Fontillas RC, Schadler K, Xiao L, Wang X, Fogelman D, Sahai SK, Lee JE, Basen-Engquist K, Katz MHG. Home-Based Exercise Prehabilitation During Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical Function and Quality of Life. Integr Cancer Ther. 2019 Jan.18. Pubmedid: 31858837. Pmcid: PMC7050956.
    • Parker NH, Lee RE, O'Connor DP, Ngo-Huang A, Petzel MQB, Schadler K, Wang X, Xiao L, Fogelman D, Simpson R, Fleming JB, Lee JE, Tzeng CD, Sahai SK, Basen-Engquist K, Katz MHG. Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study. J Phys Act Health. 2019 Dec.16(12):1113-1122. Pubmedid: 31592772. Pmcid: PMC8390122.
    • Parker NH, Arlinghaus KR, Johnston CA. Integrating Physical Activity Into Clinical Cancer Care. Am J Lifestyle Med. 2018 Mar.12(3):220-223. Pubmedid: 30283253. Pmcid: PMC6124961.
    • Cloyd JM, Nogueras-González GM, Prakash LR, Petzel MQB, Parker NH, Ngo-Huang AT, Fogelman D, Denbo JW, Garg N, Kim MP, Lee JE, Tzeng CD, Fleming JB, Katz MHG. Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy. J Gastrointest Surg. 2018 Apr.22(4):703-712. Pubmedid: 29230694. Pmcid: PMC6022283.
    • Chéry L, Borregales LD, Fellman B, Urbauer DL, Garg N, Parker N, Katz MHG, Wood CG, Karam JA. The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma. Urology. 2017 Oct.108:114-121. Pubmedid: 28705573. Pmcid: PMC5790178.
    • Lee RE, Parker NH, Soltero EG, Ledoux TA, Mama SK, McNeill L. Sustainability via Active Garden Education (SAGE): results from two feasibility pilot studies. BMC Public Health. 2017 Mar.17(1):242. Pubmedid: 28283032. Pmcid: PMC5345144.
    • Prakash L, Bhosale P, Cloyd J, Kim M, Parker N, Yao J, Dasari A, Halperin D, Aloia T, Lee JE, Vauthey JN, Fleming JB, Katz MH. Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2017 Jan.21(1):155-163. Pubmedid: 27634306.
    • Cloyd JM, Tran Cao HS, Petzel MQ, Denbo JW, Parker NH, Nogueras-González GM, Liles JS, Kim MP, Lee JE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol. 2017 Feb.115(2):144-150. Pubmedid: 27859270.
    • Ngo-Huang A, Parker NH, Wang X, Petzel MQB, Fogelman D, Schadler KL, Bruera E, Fleming JB, Lee JE, Katz MHG. Home-based exercise during preoperative therapy for pancreatic cancer. Langenbecks Arch Surg. 2017 Dec.402(8):1175-1185. Pubmedid: 28710540. Pmcid: PMC8372869.
    • Ngo-Huang A, Parker N, Martinez VA, Petzel MQ, Fogelman D, Holmes HM, Dhah SS, Katz M. Poster 68 Feasibility of a Prehabilitation Program for Patients with Potentially Resectable Pancreatic Cancer: Pilot Study. PM R. 2016 Sep.8(9S):S183. Pubmedid: 27672836.
    • Parker N, Atrooshi D, Lévesque L, Jauregui E, Barquera S, Taylor JL, Lee RE. Physical Activity and Anthropometric Characteristics Among Urban Youth in Mexico: A Cross-Sectional Study. J Phys Act Health. 2016 Oct.13(10):1063-1069. Pubmedid: 27256635. Pmcid: PMC8460133.
    • Mise Y, Day RW, Vauthey JN, Brudvik KW, Schwarz L, Prakash L, Parker NH, Katz MH, Conrad C, Lee JE, Fleming JB, Aloia TA. After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant Readmissions. J Gastrointest Surg. 2016 Jan.20(1):77-84. Pubmedid: 26493976.
    • Parker NH, O'Connor DP, Kao DT, Lee RE. Do Neighborhood Physical Activity Resources and Land Use Influence Physical Activity among African American Public Housing Residents?. J Health Care Poor Underserved. 2016 Aug.27(3):1330-1344. Pubmedid: 27524771. Pmcid: PMC8300560.
    • Layne CS, Parker NH, Soltero EG, Rosales Chavez J, O'Connor DP, Gallagher MR, Lee RE. Are physical activity studies in Hispanics meeting reporting guidelines for continuous monitoring technology? A systematic review. BMC Public Health. 2015 Sep.15:917. Pubmedid: 26384488. Pmcid: PMC4575489.
    • Liu L, Katz MH, Lee SM, Fischer LK, Prakash L, Parker N, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Maitra A, Fleming JB, Estrella J, Rashid A, Wang H. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Am J Surg Pathol. 2015 Oct.39(10):1395-1403. Pubmedid: 26200098.
    • Schwarz L, Bruno M, Parker NH, Prakash L, Mise Y, Lee JE, Vauthey JN, Aloia TA, Conrad C, Fleming JB, Katz MH. Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy. Ann Surg Oncol. 2015 Oct.22(11):3522-3529. Pubmedid: 25694246.
    • Lee RE, Hallett AM, Parker N, Kudia O, Kao D, Modelska M, Rifai H, O'Connor DP. Development of the policy indicator checklist: a tool to identify and measure policies for calorie-dense foods and sugar-sweetened beverages across multiple settings. Am J Public Health. 2015 May.105(5):1036-1043. Pubmedid: 25790397. Pmcid: PMC4386520.
    • Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH. Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Ann Surg Oncol. 2015 Jul.22(7):2416-2423. Pubmedid: 25519927.
    • O'Connor DP, Lee RE, Mehta P, Thompson D, Bhargava A, Carlson C, Kao D, Layne CS, Ledoux T, O'Connor T, Rifai H, Gulley L, Hallett AM, Kudia O, Joseph S, Modelska M, Ortega D, Parker N, Stevens A. Childhood Obesity Research Demonstration project: cross-site evaluation methods. Child Obes. 2015 Feb.11(1):92-103. Pubmedid: 25679060. Pmcid: PMC4323026.
    • Mise Y, Vauthey JN, Zimmitti G, Parker NH, Conrad C, Aloia TA, Lee JE, Fleming JB, Katz MH. Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality. Ann Surg. 2015 Dec.262(6):1071-1078. Pubmedid: 25590497. Pmcid: PMC4633391.
    • O'Connor TM, Cerin E, Lee RE, Parker N, Chen TA, Hughes SO, Mendoza JA, Baranowski T. Environmental and cultural correlates of physical activity parenting practices among Latino parents with preschool-aged children: Niños Activos. BMC Public Health. 2014 Jul.14:707. Pubmedid: 25011669. Pmcid: PMC4226995.
    • Cooper AB, Holmes HM, des Bordes JK, Fogelman D, Parker NH, Lee JE, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. J Am Coll Surg. 2014 Jul.219(1):111-120. Pubmedid: 24856952.
    • Vellani KH, Emery RJ, Parker N. Staffing benchmarks: a model for determining how many security officers are enough. J Healthc Prot Manage. 2012 Nov.28(2):1-11. Pubmedid: 22970614.
    • Petzel MQ, Parker NH, Valentine AD, Simard S, Nogueras-Gonzalez GM, Lee JE, Pisters PW, Vauthey JN, Fleming JB, Katz MH. Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumors. Ann Surg Oncol. 2012 Dec.19(13):4078-4084. Pubmedid: 22875648.
  • Grants

    • Title: Exercise Prehabilitation for Locoregional Esophageal Cancer
      Sponsor: Salgi Esophageal Cancer Research Found
      PI: Parker, N., CO-PI: Pimiento, J.
    • Title: Tele-Resistance Training During Chemotherapy for Advanced Upper Gastrointestinal Cancer
      Sponsor: Nat Institutes of Health
      PI: Parker, N.

Find a Researcher Search